Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhTPO in Children with Solid Tumors and Lymphoma Receiving ICE Chemotherapy
NCT00187109Phase 2Completed
- Sponsor
- St. Jude Children's Research Hospital
- Start
- Jun 2000
- Primary completion
- Feb 2007
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of recombinant human thrombopoietin in Thrombocytopenia, sponsored by St. Jude Children's Research Hospital. Primary endpoints: Safety of recombinant human thrombopoietin and Time to platelet count recovery. Started Jun 2000; status: completed.
02
Drugs
recombinant human thrombopoietin
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT00187109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00187109.